A multicentre prospective, open label, 3 weeks phase IV study to evaluate the efficacy and safety [of zolpidem] in elderly patients with insomnia in China
Phase of Trial: Phase IV
Latest Information Update: 23 Apr 2013
At a glance
- Drugs Zolpidem (Primary)
- Indications Insomnia
- Focus Therapeutic Use
- Acronyms STEP
- Sponsors Sanofi
- 12 Jun 2008 Status changed from in progress to completed as reported by ClinicalTrials.gov.
- 12 Mar 2008 Status changed from recruiting to in progress as reported by ClinicalTrials.gov.
- 20 Sep 2006 New trial record.